Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Spero Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Spero Therapeutics Inc
Rating: 2.00600
Author: Trendlyne DVM scores

about

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

1.26 -0.01 (-0.79%)

59.09% Fall from 52W High

458.5K

XNAS Volume

XNAS 07 Aug, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Spero Therapeutics Inc is on 12 Aug 2026 for the purpose of Spero Therapeutics Inc Second Quarter Earnings Result for 2026 See details

Not Eligible

Affordable Valuation

53.0 / 100

Technically Bearish

27.2 / 100

1Yr Price target upside is 217%

1 analysts

Spero Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Spero Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, teb...

59.09% Fall from 52W High

SWOT Analysis

Spero Therapeutics Inc Live Price Chart

Spero Therapeutics Inc Live Price Chart